Construction and identification of recombinant adenovirus with COX-2-shRNA

Chinese Journal of Biologicals

Volumn 26, Issue 8, 2013, Pages 1072-1077

  Dong, Jin Yu ^a   Wang, Qin ^a   Liang, Qin Dong ^a   Li, Wu Xian ^a   Ma, Ting Ting ^a   Xiong, Hai Yu ^a   Li, Zi Wei ^a   Tu, Zhi Guang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus; Cyclooxygenase (COX)gere; Gene therapy; Liver cancer; shRNA

Indexed keywords

CYCLOOXYGENASE 2; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; SHORT HAIRPIN RNA;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; ENZYME METABOLISM; LIVER CANCER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RECOMBINANT ADENOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; WESTERN BLOTTING;

EID: 84884484794     PISSN: 10045503     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Yao DF, Jiang H, Yao M, et al. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma [J]. Hepatobiliary Pancreat Dis Int, 2009, 8(4): 407-413.
2. Cervello M, Foderòa D, Florena AM, et al. Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis [J]. World J Gastroenterol, 2005, 11(30): 4638-4643. (Pubitemid 41179515)
3. Cervello M, Montalto G. Cyclooxygenases in hepatocellular carcinoma [J]. World J Gastroenterol, 2006, 12(32): 5113-5121. (Pubitemid 44355906)
4. Dohmen K, Okabe H, Ishibashi H. Regression of hepatocellular carcinoma due to cyclooxygenase (COX)-2 inhibitor [J]. Am J Gastroenterol, 2006, 101(10): 2437-2438. (Pubitemid 44477577)
5. Thomas MB, Zhu AX. Hepatocellular carcinoma: the need for progress [J]. J Clin Oncol, 2005, 23(13): 2892-2899. (Pubitemid 46224106)
6. Corcoran CA, He Q, Huang Y, et al. Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis [J]. Oncogene, 2005, 24 (9): 1634-1640. (Pubitemid 40396093)
7. Niesporek S, Kristiansen G, Thoma A, et al. Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression [J]. Int J Oncol, 2008, 32 (2): 341-347. (Pubitemid 351188300)
8. Kang MK, Park W, Choi YL, et al. The effect of cyclooxygenase-2 expression on tumor volume response in patients treated with radiotherapy for cervical cancer [J]. J Korean Med Sci, 2009, 24 (6): 1170-1176.
9. Li GP, Yang T. Cyclooxy genase-2 and tumor progression [J]. Sheng Li Ke Xue Jin Zhan, 2003, 34 (1): 83-85.
10. Strillacci A, Griffoni C, Spisni E, et al. RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumor cells [J]. Br J Cancer, 2006, 94 (9): 1300-1310.
11. Charames GS, Bapat B. Cyclooxygenase-2 knockdown by RNA interference in colon cancer [J]. Int J Oncol, 2006, 28(2): 543-549.
12. Narvaiza I, Aparicio O, Vera M, et al. Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing [J]. J Viral, 2006, 80 (24): 12236-12247.